Home Genentech

Genentech

acquired
IPO Delisting
Pharmaceutical R&D Manufacturer
Basic
Enterprise Profile
LinkedIn

Basic Information

Genentech is a biotechnology company founded in 1976 by Robert Swanson and Herbert Boyer, dedicated to researching and developing medicines to treat patients with serious or life-threatening diseases. Our transformative discoveries include the first targeted antibody for cancer and the first treatment for primary progressive multiple sclerosis.
Genentech, Inc.
California,United States of America
more than 500 people
January 01, 1976
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Immune Cell Therapy Biological Drug Production
Technology
Targeted Technology Protein Technology
Concept
Department of Rheumatology and Immunology Therapeutic Products # Liver Cancer Lung Cancer Esophageal Cancer Lymphoma Colorectal Cancer Prostate Cancer Lupus Erythematosus
Application Scenarios
Innovative Drugs Monoclonal Antibody Bispecific Antibody ADC (Antibody-Drug Conjugate) Nucleic Acid Drugs